Neonatology Research

Philadelphia is the poorest large city in the country. Children living in Philadelphia face a number of environmental threats to their health every day — from lead poisoning and air pollution to exposure to asbestos and endocrine-disrupting chemicals, the compounds found in household products and the environment that have been linked to preterm birth. In an effort to address these hazards and identify and protect pregnant people and their children who live in the region's most vulnerable communities, Attending Neonatologist Rebecca Simmons, MD, and colleagues at Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania are joining forces by integrating their expertise in the new Philadelphia Regional Center for Children’s Environmental Health (PRCCEH NOTE-once the website is up and running we can provide the link here) funded by the National Institutes of Health (NIH). The team’s goal is to stimulate new translational research projects and increase awareness by disseminating children's environmental health knowledge to healthcare providers, community members and policy makers. Current projects are examining the links between several environmental factors including air pollution, green space, endocrine disruptors and preterm birth. 

• Rebeccca A. Simmons, MD
• Colin Conine, PhD
• Scott Gordon, MD, PhD
• Heather H. Burris, MD
• Scott A. Lorch, MD, MSCE

• Eric C. Eichenwald, MD
• Sara B. DeMauro, MD, MSCE
• Erik Jensen, MD, MSCE
• Scott A. Lorch, MD, MSCE

Extensive efforts to understand the association of early-life perturbations with later onset of metabolic diseases, the founding principle of developmental origins of health and disease, have been crucial in determining the mechanisms that drive the later development of diseases. As the programming of the epigenome occurs during critical periods of development, it has emerged as a potential molecular mechanism that could occur early in life and impact metabolic health decades later. Research in the Conine Lab and Simmons Lab focuses epigenetic mechanisms which have a potential to be influenced by extrinsic environmental factors (such as diet, physical activity, in utero environment, chemical exposure and stress). It is critical to identify epigenetic targets that are modified following suboptimal environment early in life and determine their contribution to the development of a disease phenotype later in life and possibly its progeny. We are investigating novel diagnostic tools and developing innovative therapeutic strategies to prevent the later development of obesity and diabetes.

• Rebeccca A. Simmons, MD
• Colin Conine, PhD

CHOP’s Division of Neonatology is at the forefront of paradigm-changing research in basic/translational and clinical research in the field of neonatal lung development, pathophysiology, clinical interventions and outcomes. Publications from the division have already changed the dialogue about how neonatal lung diseases are diagnosed and treated. We also have a unique and large multidisciplinary program dedicated to bronchopulmonary dysplasia, which provides a unique opportunity to learn from this patient population with the goal of providing the best and most accurate therapy for each patient. Several NIH-funded investigators are working in this area and have a stellar track record of mentoring trainees. 

• Krithika Lingappan, MD, PhD, MS
• G. Scott Worthen, MD
• Shaon Sengupta, MBBS, MPH
• Danielle A. Callaway, MD, PhD
• Erik Jensen, MD, MSCE
• Nicolas Bamat, MD, MSCE

The March of Dimes Prematurity Research Center at the University of Pennsylvania — led by CHOP Attending Neonatologist Rebecca Simmons, MD, and Penn Medicine Maternal-Fetal Medicine Specialist Samuel Parry, MD — is one of five national and international centers dedicated to identifying the causes of preterm birth that will result in more effective strategies to prevent preterm birth in the future. Penn’s transdisciplinary team of investigators with expertise in obstetrics, pediatrics, neonatology, genetics, metabolism, cell and developmental biology, bioengineering, microbiology, and reproductive biology are working together to solve this problem. Research is currently focused on understanding the mechanisms that underlie placenta dysfunction and the link to preterm birth and how the maternal immune system and the developing placenta communicate with each other. 

• Rebeccca A. Simmons, MD
• Colin Conine, PhD
• Scott Gordon, MD, PhD
• Heather H. Burris, MD

• Andrea F. Duncan, MD, MS
• Sara DeMauro, MD, MSCE

• Scott Gordon, MD, PhD
• Kathryn Rubey, MD
• G. Scott Worthen, MD
• Dustin D. Flannery, DO, MSCE
• Lakshmi Srinivasan, MD, FAAP
• Mary C. Harris, MD
• Karen M. Puopolo, MD, PhD
• Sagori Mukhopadhyay, MD, MMSc
• Carolyn McGann, MD

Health Policy

• Diana Montoya-Williams, MD
• Scott A. Lorch, MD, MSCE
• Sara Handley, MD, MSCE

Racial/Ethnic Disparities

• Rebeccca A. Simmons, MD
• Heather H. Burris, MD
• Diana Montoya-Williams, MD
• Scott A. Lorch, MD, MSCE

Quality of Care Assessment

• Scott A. Lorch, MD, MSCE
• Sara Handley, MD, MSCE

Community Drivers of Outcomes

• Diana Montoya-Williams, MD
• Heather H. Burris, MD
• Scott A. Lorch, MD, MSCE

Hospital Characteristics and Systems

• Scott A. Lorch, MD, MSCE
• Sara Handley, MD, MSCE

• Heidi Herrick, MD
• Elizabeth E. Foglia, MD, MA, MSCE